Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
WLmkfhkjhQD3XBbH